Practicing smart with a high-value choice
Stress echo screening for patients at high risk of requiring an invasive cardiac procedure may spare patients a more intrusive and costly experience. Results recently presented at the American Academy of Family Physicians’ conference, Family Medical Experience, suggested patients who do not require invasive intervention could effectively and safely avoid further testing through the use of this technology.
Check out these other recent publications:
The findings of this real-world investigation suggest sacubitril/valsartan is associated with symptom improvements and a reduction in hospitalizations for patients with heart failure and reduced ejection fraction. , link opens new window
And more . . .
Ways to connect: Have questions or want to share an idea for other research opportunities? Email Courtney Brown at email@example.com
Interested in seeing more research? Visit Humana’s research site to learn about past research projects, listen to podcasts, and view videos that showcase Humana’s commitment to research. Access our highlighted research here, link opens new window or visit our full research library here, link opens new window.